ALLERGIC RHINOCONJUNCTIVITIS
Clinical trials for ALLERGIC RHINOCONJUNCTIVITIS explained in plain language.
Never miss a new study
Get alerted when new ALLERGIC RHINOCONJUNCTIVITIS trials appear
Sign up with your email to follow new studies for ALLERGIC RHINOCONJUNCTIVITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for severe hay fever sufferers
Symptom relief CompletedThis study tested whether a grass pollen tablet (SLIT) combined with the drug dupilumab could help adults with moderate to severe seasonal allergies tolerate grass pollen better. About 199 participants received the combination or a placebo for two years. The goal was to see if th…
Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Symptom relief
Last updated May 26, 2026 12:11 UTC
-
New allergy treatment could help kids breathe easy during birch season
Symptom relief CompletedThis study tested a treatment called STALORAL Birch 300 IR in children and teens aged 5 to 17 with birch pollen allergies. The goal was to see if it safely reduces symptoms like sneezing, runny nose, and itchy eyes during pollen season. About 553 participants took part across mul…
Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS
Phase: PHASE3 • Sponsor: Stallergenes Greer • Aim: Symptom relief
Last updated May 26, 2026 12:05 UTC
-
New allergy pill shows promise in ragweed season trial
Symptom relief CompletedThis study tested a new drug called BLU-808 in 21 adults with ragweed allergies. Participants were exposed to ragweed pollen in a special chamber to see if the drug safely reduces allergy symptoms like sneezing and itchy eyes. The goal was to check safety and how well the drug wo…
Matched conditions: ALLERGIC RHINOCONJUNCTIVITIS
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC